Use Of RFID Asset Management Systems For Monitoring Analytical Instrumentation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Use Of RFID Asset Management Systems For Monitoring Analytical Instrumentation


Pharmaceutical Technology Europe
Volume 22, Issue 9

RFID and the pharma industry

RFID can increase the safety and visibility of pharmaceutical products — from raw materials, through to manufacturing and patient consumption — by allowing the tracking and tracing of medications at the item level at each stage of the supply chain, preventing theft and effectively facilitating management of product recalls to ultimately assure pharmaceutical integrity. As such, the FDA has recommended the use of RFID tags to better integrate and improve the safety of US medical supply chains.3

For the analytical laboratory, managing and tracking high-end and portable equipment and associated documentation is a core requirement of laboratory management systems. Doing this 'well' with minimal resource and manual intervention and in a compliant manner is the key to successful application of RFID in the laboratory. Current systems used in pharmaceutical, biotech and other regulated environments include simple hard copy inventory lists, spreadsheets, barcoding systems and enterprise resource program (ERP) systems.

Historically, inventory lists were maintained to monitor asset depreciation or as part of various financial or laboratory management systems. Lack of information or incorrect information about location, status and usage can, however, cause delays in laboratory operations or lead to excess inventory of costly assets. Often, information is available, but is stored in different physical locations, systems or databases. As a result, the ability to defend a laboratory during a regulatory audit can become difficult. If the integrity of documentation, such as service and maintenance logs, installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ) records is compromised, then regulated laboratories are under risk of noncompliance. If documents pertaining to maintenance, qualification and change management are stored in one compliant database, defence of the laboratory becomes much easier from a holistic perspective.

Integration of RFID technology with compliant database architecture represents a significant step forward in managing laboratory assets "well", and in a compliant manner.

Features of an RFID-based asset management solution include:

  • Real-time management of individual assets or groups of assets.
  • Location of assets, locally, regionally or globally.
  • Provision of current instrument status including service history.
  • Retention of the history of an asset and audit trail of the asset's lifecycle.
  • Tamper alert messaging for unauthorised movement of assets that would void equipment qualification in a regulated environment.
  • Monitoring of laboratory temperature and humidity with audit trail and alerting mechanism.
  • A web-based enterprise system that provides total laboratory asset management.


Table 1: Benefits of an RFID-based asset management system compared with traditional barcode and ERP systems.
The benefits of an RFID system compared with traditional barcode and ERP asset management systems are summarised in Table 1.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here